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Abstract
Background: C21, the C-terminal peptide of thrombospondin-4, has growth promoting activity
and was discovered as one of several erythropoietin-dependent endothelial proteins. C21
stimulates red cell formation in anemic mice and is a growth factor for CD34+ and CD36+
hematopoietic cells, skin fibroblasts and kidney epithelial cells. ROD1 has been identified as an
intracellular mediator. Nothing is known about the existence of putative C21 receptors on plasma
membranes of target cells.
Findings: We analyzed the nature of C21-binding proteins in cell lysates of skin fibroblasts using
C21 affinity columns. The membrane receptor CD44 was identified as C21-binding protein by mass
spectrometry. We were unable to demonstrate any direct involvement of CD44 on cell growth or
the effect of C21 on cell proliferation. A soluble form of CD44 was synthesized in insect cells and
purified from culture supernatants with a combination of PVDF filtration in the presence of
ammonium sulphate and HPLC. Both osteopontin and hyaluronic acid competitively displaced
Biotin-C21 binding to CD44. In a colony-forming assay using primitive CD133+ hematopoietic
stem cells from cord blood, osteopontin and C21 had opposite effects and C21 reduced the
inhibitory action of osteopontin.
Conclusion:  CD44 is a C21-binding membrane protein. We could not demonstrate an
involvement of CD44 in the proliferative action of C21. Nevertheless, based on the antagonism of
C21 and osteopontin in hematopoietic precursors, we speculate that C21 could indirectly have a
major impact on hematopoietic stem cell proliferation, by hindering osteopontin membrane binding
at the level of the bone marrow niche.
Background
Erythropoietin (EPO) is the most important cytokine
involved in the production of red cells [1]. In endothelial
cells, EPO stimulates the synthesis of proteins involved in
red cell formation, such as thrombospondins (TSPs) 1
and 4 [2,3]. TSPs are very large extracellular matrix glyco-
proteins with multiple functions [4]. The biological activ-
ity of the C-terminal, amphipathic peptide of TSP-4 (C21)
has been described only recently [2] and therefore noth-
ing is known about putative membrane receptors for the
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peptide on the surface of target cells. Our results on the
search for potential C21 receptors can be summarized in
three points: (1) CD44 was identified as a C21-binding
membrane protein in lysates of skin fibroblasts, but we
were not able to demonstrate a direct involvement of
CD44 in the mitogenic action of C21. (2) Binding studies
with a recombinant CD44 indicated that osteopontin
(OPN) competed with C21 for CD44 binding, suggesting
a possible function of C21 as OPN antagonist. (3) C21
and OPN had opposite effects on colony formation in cul-
tures of primitive hematopoietic stem cells. Therefore, we
speculate that C21 binding to CD44 could indirectly stim-
ulate hematopoietic stem cell proliferation by preventing
the inhibitory action of osteopontin (OPN).
Methods
Cell cultures of human skin fibroblasts, 293T kidney epi-
thelial cells and Trichoplusia ni insect cells (TN) were
done as previously described [5,6]. Cord blood CD133+
precursor cells (Lonza) were cultured in methylcellulose
medium (Methocult H4536, Stem Cell Technologies)
supplemented with 3 U/ml EPO in the presence of 1 μM
C21 [5] or 0.5 μg/ml recombinant human osteopontin
(OPN, carrier-free, R&D Systems). The cells (5000/ml)
were plated on 12-well plates (Costar, 0.5 ml/well). The
plasmid pENTR containing the cDNA coding for tran-
script 4 of human CD44, CD44v4 (Ultimate ORF Clone
Collection, ID IOH53593, Invitrogen) was modified to
introduce a stop codon at the beginning of the extracellu-
lar section of the transmembrane domain of CD44 with
the "QuikChange®" Site directed mutagenesis kit (Strata-
gene). The modified cDNA was integrated into the desti-
nation vector pIB/V5-His-DEST with clonase (Invitrogen
Gateway™ technology) for insect cell production and the
complete CD44 sequence was integrated using the same
method into the pLenti6/V5-DEST plasmid for lentiviral
transduction in 293T cells.
C21-affinity chromatography, gel electrophoresis and MS
analysis were done as previously described [5].
Soluble CD44 was isolated from three day supernatants of
cultures from transfected TN cells cultured in serum-free
Excel 405 medium (Sigma). 100 ml of ice-cold medium
were mixed with 2 M Tris-HCl, pH 8 to a final Tris concen-
tration of 0.1 M and stirred for 10 min. The precipitated
proteins were separated by centrifugation at 10,000 × g for
20 min. The supernatant was mixed with 6 g SM-2
Adsorbent beads (Bio-Rad) and further stirred on ice for
20 min. The beads were trapped with 4 layers of cheese
cloth and the remaining medium was mixed with 43 g
ammonium sulfate and stirred for 1 h. The precipitated
proteins were eliminated by centrifugation (20 min,
10,000 × g) and the supernatant was filtered through
Durapore PVDF membranes (0.22 μm, Cat. SCGVU02RE,
Millipore). The filter was cut in pieces, gently shook on a
nutator at 8°C for 20 min, first with 5 ml 0.3% (w/v)
Zwittergent 3-16 (Calbiochem) and then with 5 ml 1%
(v/v) Triflouroacetic acid (TFA). The two extracts were
mixed, warmed up to room temperature and applied to a
Vydac semi-preparative C4 column (10 × 250 mm, Cat
214TP1010, Grace/Vydac). The column was washed with
30 ml 0.1%TFA and the extract components separated
with a gradient of acetonitrile [7]. The collected fractions
were immediately lyophilized, dissolved in 60 μl of the
storage buffer [5]. The fractions containing CD44 were
identified by applying 2 μl on nitrocellulose paper. The
dot blots were developed, scanned and measured as previ-
ously indicated [8]. We used a monoclonal anti-CD44
antibody recognizing all CD44 isoforms (R&D Systems).
Digestion of CD44 with peptide:N-glycosidase F (PNGase
F, New England Biolabs) was done following the instruc-
tions of the manufacturer. Binding of biotinylated C21
(Biotin-C21) to CD44 on nitrocellulose membranes was
done as previously described for ROD1 [5]. Binding com-
petition studies were done with the same OPN prepara-
tion utilized for cell culture as indicated above and with
human umbilical cord hyaluronic acid (potassium salt,
Calbiochem).
Results and discussion
Identification and potential significance of CD44 as a C21 
binding protein
CD44 is the only C21-binding cell membrane protein
identified so far by mass spectrometry using the C21 affin-
ity chromatography described in Methods. The Mascot
(Matrix Science) search program indicated a match to
CD44E [GenBank:CAA38951]. We found that another
C21-binding protein, the nuclear protein ROD1, plays an
active role on the mitogenic activity of C21 [5]. Our orig-
inal hypothesis was that C21 binds first to CD44, is inter-
nalized (as has been demonstrated with the CD44 ligand
hyalurodan [9]), goes to the nucleus and binds regulatory
proteins such as ROD1, resulting in an inhibition of dif-
ferentiation and/or stimulation of cell proliferation.
ROD1 overexpression in skin fibroblasts and 293T cells
resulted in an increased basal cell proliferation and in an
enhancement of the mitogenic activity of C21 [5]. Insect
cells stably transfected with ROD1 grew faster than non
transfected or β-galactosidase-expressing cells (Fig 1). This
is not surprising, because human ROD1 is active in lower
eukaryotes such as yeast [10]. Although CD44-like,
hyaluronic acid-binding proteins have been identified in
primitive invertebrates [11], proliferation of stably CD44
transfected insect cells was not significantly different from
that observed in β-galactosidase-transfected cells (Figure
1). The same was the case with 293T cells transduced with
the complete CD44 sequence. We could not see any sig-
nificant changes in basal- or C21-mediated increase of cell
proliferation (results not shown). The problem with over-BMC Research Notes 2009, 2:215 http://www.biomedcentral.com/1756-0500/2/215
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expression experiments is that negative results are incon-
clusive. This is particularly valid in the case of CD44. We
are overexpressing only one of the many isoforms pro-
duced by alternative splicing [12] and a negative result
with only one of the transcripts can not exclude the possi-
bility that other CD44 molecules may be active.
Biotin-C21 binding to CD44 is inhibited by hyaluronic acid 
and osteopontin
If CD44 is not implicated in the action of C21, it is still
possible that C21-CD44 interactions may have an effect in
the function of the membrane receptor in its capacity as a
cell-adhesion molecule. The best known ligand of CD44
is hyaluronic acid (HA, hyaluronan), a ubiquitous cell
matrix component, which plays an important role in
hematopoiesis [13]. Of particular importance is the HA of
the endosteal bone marrow niche, which plays a role in
primitive hematopoietic stem cell proliferation and hom-
ing of transplanted cells to the marrow [14,15]. OPN,
another CD44 ligand, is a negative regulatory protein of
the hematopoietic stem cell niche [16,17].
Therefore, it was important to investigate the possible
interference of C21 with binding to these two CD44 lig-
ands, because it could indirectly play a role in homing and
proliferation. For these purpose, we designed a soluble
CD44 molecule from a CD44v4 cDNA as indicated in
Methods and expressed the recombinant protein using
insect cells. The method utilized solved a major technical
problem of recombinant protein purification from cell
culture supernatants: elimination of xenobiotic compo-
nents, found in yeast-extract-based serum-free media uti-
lized for protein production with insect or mammalian
cells. For the first purification step, we utilized ammo-
nium sulfate precipitation [18]. The human recombinant
CD44 produced in insect cells could not be precipitated
with ammonium sulfate. Nevertheless, we found that if a
CD44 solution is filtered through PVDF membranes in
the presence of ammonium sulfate, there is complete
retention on the membranes (Figure 2A). This was not
observed in the absence of ammonium sulfate. Retention
without precipitation could be attributed to a Hofmeister
ion effect [19,20] Figure 2B shows the importance of the
utilization of PVDF for the retention of CD44. If superna-
tants are desalted by ultrafiltration, the vast majority of
the culture contaminants are retained and CD44 recovery
is low (Figure 2B). However, if PVDF retained material is
solubilized and applied to HPLC columns, the vast major-
ity of the contaminants of Figure 2B is eliminated and the
recovery of CD44 is high (Fig 2C). MS analysis of the pro-
tein indicated that it corresponded to human CD44R1,
[GenBank:CAA40133], a hematopoietic cell isoform of
CD44 [21]. Treatment with a recombinant glycosidase
indicated that the protein was extensively N-glycosylated
by insect cells (Figure 2C).
This protein was utilized to study the possible competi-
tion of biotin-C21 binding to CD44 by HA (Figure 3A)
and OPN (Figure 3B). Both HA and OPN displaced
Biotin-C21 binding to CD44. Surprisingly, the inhibition
of Biotin-C21 binding caused by increasing amounts of
C21 and OPN was practically identical (Figure 3B), sug-
gesting common binding sites for the TSP-4 peptide and
OPN. A similar comparison of C21 with HA was not pos-
sible, due to the undefined, heterogeneous molecular
weight of the HA preparation.
Opposite effects of C21 and OPN on colony formation of 
CD133+ cord blood cells
The most important function of OPN in hematopoiesis
seems to be the suppression of proliferation of primitive
stem cells in the bone marrow niche, as evidenced with
OPN-/- mice and in vitro colony formation assays [16,17].
The effect of OPN depends on the differentiation state of
the stem cells. The inhibitory action is eliminated with the
appearance of the cell marker CD38+ [17] and in highly
differentiated, primary erythroblasts, OPN actually stimu-
Effects of CD44 on insect cell proliferation Figure 1
Effects of CD44 on insect cell proliferation. TN insect 
cells were permanently transfected with ROD1 [5] or CD44 
as indicated in Methods and their growth in culture was com-
pared with parallel control cell cultures transfected with β-
galactosidase. The increase in cell numbers observed in 
ROD1 or CD44 transfected cultures was expressed as per-
centage of the number of cells observed in β-galactosidase 
transfected cells after the same day in culture. The values are 
mean ± SEM, from 5 to 6 experiments. Only the effects of 
ROD1 were statistically different from the controls (Krustal-
Wallis and Dunn's multiple comparisons test). *, P < 0.05. **, 
P < 0.01.
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Preparation of a soluble form of CD44 from insect cell culture medium Figure 2
Preparation of a soluble form of CD44 from insect cell culture medium. (A) Ammonium sulfate is responsible for 
retention of soluble CD44 on PVDF filters. 22 μg CD44 prepared as indicated in Methods were dissolved in 0.3 ml 0.1 M Tris-
HCl, pH8 and filtered through Millex-GV low protein binding Durapore, 0.22 μm pore size (Millipore SLGV033RS) in Tris 
buffer alone or with 3 M ammonium sulfate. The ultrafiltrates of ammonium-sulfate containing solutions were practically free of 
immunoreactive CD44, measured as indicated in Methods. Values are mean ± SEM (n = 4). (B) Reverse phase HPLC of the sol-
uble ammonium sulfate fraction of cell culture supernatants. The supernatants of TN cultures expressing CD44 were proc-
essed as indicated in Methods and applied to a Vydac C4 semi-preparative column. (B1) Acetonitrile gradient, 0% to 72% (v/v) 
acetonitrile in 0.1% (v/v) TFA for 50 min, 2 ml/min. (B2) After centrifugation of the proteins precipitated with ammonium sul-
fate, the supernatant was desalted and concentrated by ultrafiltration (Centricon-20, cut-off 10 kDa, Millipore) and applied to 
the column. (B3) Instead of ultrafiltration, the supernatant was filtered through PVDF membranes (type GV, 0.22 μm). The 
proteins on the filter were extracted and applied to the column. The gray bars represent the density of the immunoreactive 
fractions using an anti-CD44 antibody. (C) PNGase digestion of recombinant soluble CD44. 120 ng CD44 were applied onto 
PAGE-SDS gels (10% acrylamide) and separated by electrophoresis before (-) and after (+) 1 h digestion with PNGase F. M = 
molecular weight markers. The gels were stained with coomassie blue.
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HA and OPN compete for Biotin-C21 binding to CD44 Figure 3
HA and OPN compete for Biotin-C21 binding to CD44. (A) Binding of Biotin-C21 to CD44 immobilized on nitrocellu-
lose membranes was displaced with increasing concentrations of HA. No displacement is considered as 100% (controls). Mean 
± SEM. n = 7. (B) Competition for Biotin-C21 binding to CD44 with increasing concentrations of C21 (closed triangles) or 
OPN (open triangles). Mean ± SEM. n = 5 for 8 μM OPN, n = 6 for 0.08 μM OPN and 0.33 μM C21, n = 8 for 0.8 μM OPN, n 
= 9 for 3.3 and 33 μM C21. P values calculated by analysis of variance and Student-Newman-Keuls test (C21 and HA) or Krus-
tal-Wallis and Dunn's multiple comparisons test (OPN).
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lates cell proliferation [22]. TSP-1 has a similar differenti-
ation-dependent effect on cell proliferation [3,5]. The
existence of opposite effects of OPN in primitive precur-
sors and differentiated cells is just one example of the
more generalized duality of OPN action. This is illustrated
by its double action as pro-inflammatory or anti-inflama-
tory cytokine, observed under normal or pathological
conditions, as recently reviewed by Wang and Denhardt
[23]. This multiplicity of biological activities, receptors
and signal transduction pathways requires a careful choice
in the nature and differentiation stage of the target cells to
be used in the experiments. OPN-dependent inhibition
by C21 has to be studied in very primitive, CD38- stem
cell precursors. We chose CD133+ cells, which can differ-
entiate into hematopoietic or endothelial cells [24,25].
For the experiments on colony formation, we used a min-
imal serum-free cell culture system without Flt3 ligand,
thrombopoietin, VEGF or stromal cell monolayers, usu-
ally required for full differentiation into granulocyte-mac-
rophage colonies, erythroid colonies or endothelial cells.
Therefore, the colonies formed were compact and small
(Figure 4A). Figure 4B shows that C21 and OPN had
opposite effects on colony formation. This antagonistic
action was significant. Although the OPN-mediated
reduction of colony formation was not significantly differ-
ent from that observed in control cell cultures in CD133+
cells, probably due to the low number of experiments, the
inhibitory action of OPN in similar, primitive hematopoi-
etic stem cells cultures is well established [16,17]. There is
a correlation between the antagonistic effects of OPN and
C21 on colony formation in vitro (Figure 4) with the
observed molecular competition for CD44 binding in sil-
ico (Figure 3). The contribution of CD44 to this antago-
nism may be limited, because C21 could stimulate
proliferation by CD44-independent pathways and OPN
action on colony formation seems to be mediated by β1
integrins rather than CD44 [17]. A CD44 involvement is
nevertheless quite possible. CD44 binding could passively
increase the local, membrane bound concentration of
OPN. The most probable scenario is that CD44 actively
participates as a coreceptor, bound in lipid rafts to
integrin chains. This association leads to integrin activa-
tion, as demonstrated in adenocarcinoma cell lines [26].
In conclusion, C21 could act on target cells by multiple
mechanisms, which may involve competition with OPN
for CD44 binding sites, ROD1-dependent signal transduc-
tion pathways involving proliferation and, probably,
ROD1- independent effects on apoptosis, as previously
discussed in [5].
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Colony formation of CD133+ cord blood cells in the pres- ence of C21 and OPN Figure 4
Colony formation of CD133+ cord blood cells in the 
presence of C21 and OPN. (A) Microscope images of 4 
typical colonies formed after 18 days in culture of CD133+ 
cells in the semisolid serum-free medium described in Meth-
ods. The "Methocult"-medium contained stem cell factor, 
GM-CSF, G-CSF, IL-3, IL-6 and EPO. The culture was not 
done on stromal cell monolayers and did not contain Flt3 lig-
and, thrombopoietin or VEGF. (B) Total colony cell count 
observed after 18 days incubation with C21, OPN or 
C21+OPN. Mean ± SEM. n = 4. P value according to Fried-
man Test (nonparametric repeated measures analysis of vari-
ance) and Dunn's multiple comparisons test.
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